Shopping Cart
- Remove All
Your shopping cart is currently empty
GSK180 is a selective competitive inhibitor of kynurenine 3-monooxygenase (KMO; IC50: ~6 nM), an enzyme involved in tryptophan metabolism.

| Pack Size | Price | Availability | Quantity |
|---|---|---|---|
| 2 mg | $86 | 5 days | |
| 5 mg | $140 | 5 days | |
| 1 mL x 10 mM (in DMSO) | $133 | 5 days |
| Description | GSK180 is a selective competitive inhibitor of kynurenine 3-monooxygenase (KMO; IC50: ~6 nM), an enzyme involved in tryptophan metabolism. |
| Targets&IC50 | KMO:~6 nM |
| In vitro | GSK180 inhibits endogenous KMO activity in primary human hepatocytes (IC50=2.6 μM) and it also inhibits rat KMO slightly less potently than the human enzyme (IC50=7 μM). |
| In vivo | GSK180 is fit for i.v. management [1]. |
| Molecular Weight | 276.07 |
| Formula | C10H7Cl2NO4 |
| Cas No. | 1799725-26-0 |
| Relative Density. | 1.626 g/cm3 (Predicted) |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.